Advertisement
Screener

Kazia Therapeutics Limited. (KZIA) Cash And Cash Equivalents

Kazia Therapeutics Limited. Cash And Cash Equivalents

Kazia Therapeutics Limited. (KZIA) had Cash And Cash Equivalents of AUD 69.46 million as of 2025-12-31, per its 6-K filed 2026-03-30.

Financial Statements › Notes

ifrs-full:CashAndCashEquivalents · last filed 2026-03-30

  • 2025-12-31: Cash And Cash Equivalents 69.46M AUD.
  • 2025-06-30: Cash And Cash Equivalents 4.34M AUD; Cash And Cash Equivalents as first filed 4.34M AUD.
  • 2024-12-31: Cash And Cash Equivalents 3.06M AUD.
  • 2024-06-30: Cash And Cash Equivalents 1.66M AUD; Cash And Cash Equivalents as first filed 1.66M AUD.
Period endCash And Cash EquivalentsCash And Cash Equivalents as first filed
2025-12-3169.46M AUD
6-K · filed 2026-03-30
2025-06-304.34M AUD
6-K · filed 2026-03-30
4.34M AUD
20-F · filed 2025-11-07
2024-12-313.06M AUD
6-K · filed 2026-03-30
2024-06-301.66M AUD
6-K · filed 2026-03-30
1.66M AUD
20-F · filed 2024-11-15
2023-12-313.56M AUD
6-K · filed 2025-06-10
2023-06-305.24M AUD
20-F · filed 2025-11-07
5.24M AUD
20-F · filed 2023-10-26
2022-12-314.39M AUD
6-K · filed 2024-03-27
2022-06-307.36M AUD
20-F · filed 2025-11-07
7.36M AUD
20-F · filed 2022-10-17
2021-12-3115.19M AUD
6-K/A · filed 2023-03-09
2021-07-0127.59M AUD
20-F · filed 2023-10-26
2021-06-3027.59M AUD
20-F · filed 2024-11-15
27.59M AUD
20-F · filed 2021-10-07
2020-06-308.76M AUD
20-F · filed 2023-10-26
2019-06-305.43M AUD
20-F · filed 2022-10-17
2018-06-305.96M AUD
20-F · filed 2021-10-07
2017-06-3014.46M AUD
20-F · filed 2020-10-22
2016-06-3033.45M AUD
20-F · filed 2019-10-21
2015-06-3044.37M AUD
20-F · filed 2018-10-24